BR9912410A - Vacina para imunização de aves, e, processos para imunizar uma ave e para preparar uma vacina para imunizar uma ave - Google Patents

Vacina para imunização de aves, e, processos para imunizar uma ave e para preparar uma vacina para imunizar uma ave

Info

Publication number
BR9912410A
BR9912410A BR9912410-6A BR9912410A BR9912410A BR 9912410 A BR9912410 A BR 9912410A BR 9912410 A BR9912410 A BR 9912410A BR 9912410 A BR9912410 A BR 9912410A
Authority
BR
Brazil
Prior art keywords
vaccine
bird
immunize
immunizing
birds
Prior art date
Application number
BR9912410-6A
Other languages
English (en)
Inventor
Kenneth L Roland
Original Assignee
Megan Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megan Health Inc filed Critical Megan Health Inc
Publication of BR9912410A publication Critical patent/BR9912410A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"VACINA PARA IMUNIZAçãO DE AVES, E, PROCESSOS PARA IMUNIZAR UMA AVE E PARA PREPARAR UMA VACINA PARA IMUNIZAR UMA AVE". é descrita uma vacina para proteger aves contra infecção por micróbios gram-negativos patogênicos aviários. A vacina é uma cepa recombinante de Salmonella expressando antígeno O de um micróbio gramnegativo patogênico aviário tal como uma cepa de E. coli que é patogênica em ave doméstica. A cepa recombinante de Salmonella também não expressa antígeno O de Salmonella. Processos de uso da vacina para imunizar aves também são descritos.
BR9912410-6A 1998-07-24 1999-07-13 Vacina para imunização de aves, e, processos para imunizar uma ave e para preparar uma vacina para imunizar uma ave BR9912410A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/122,441 US6399074B1 (en) 1998-07-24 1998-07-24 Live attenuated salmonella vaccines to control avian pathogens
PCT/US1999/015842 WO2000004919A2 (en) 1998-07-24 1999-07-13 Live attenuated salmonella vaccines to control avian pathogens

Publications (1)

Publication Number Publication Date
BR9912410A true BR9912410A (pt) 2002-01-15

Family

ID=22402731

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912410-6A BR9912410A (pt) 1998-07-24 1999-07-13 Vacina para imunização de aves, e, processos para imunizar uma ave e para preparar uma vacina para imunizar uma ave

Country Status (10)

Country Link
US (1) US6399074B1 (pt)
EP (1) EP1100536A2 (pt)
JP (1) JP2002521345A (pt)
CN (1) CN1315871A (pt)
AU (1) AU4991499A (pt)
BR (1) BR9912410A (pt)
CA (1) CA2338555A1 (pt)
MX (1) MXPA01000884A (pt)
WO (1) WO2000004919A2 (pt)
ZA (1) ZA200100976B (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872398B2 (en) * 1995-12-22 2005-03-29 The United States Of America As Represented By The Secretary Of The Army Conjugate vaccine against gram-negative bacterial infections
US7026155B2 (en) * 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
MY128159A (en) * 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination
MXPA03008563A (es) * 2001-03-23 2005-03-07 Advanced Bionutrition Alimentos microbianos para acuacultural y agricultura.
US8133493B2 (en) * 2002-04-15 2012-03-13 Washington University Regulated attenuation of live vaccines to enhance cross-protective immunogenicity
US20050260225A1 (en) * 2004-05-18 2005-11-24 Goldberg Joanna B Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
AU2006287110B2 (en) * 2005-08-30 2012-04-12 Commonwealth Scientific And Industrial Research Organisation Bacterial delivery of biologically active polypeptides
NZ571970A (en) * 2006-04-17 2012-02-24 Schering Plough Ltd Recombinant attenuated clostridium organisms and vaccine
US20080124355A1 (en) 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
US20080115830A1 (en) * 2006-11-22 2008-05-22 High Power-Factor Ac/Dc Converter With Parallel Power Processing Test device for solar concentrator module
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
WO2008141226A2 (en) * 2007-05-10 2008-11-20 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacteria comprising vectors for expression of nucleic acid sequences encoding antigens
EP2150616A4 (en) 2007-05-10 2011-07-27 Univ Arizona REGULATED ANTIGEN SYNTHESIS AND / OR REGULATED ATTENUATION FOR IMPROVING VACCINATE IMMUNOGENICITY AND / OR SAFETY
WO2009046449A1 (en) * 2007-10-05 2009-04-09 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against enteric pathogens
US8647642B2 (en) 2008-09-18 2014-02-11 Aviex Technologies, Llc Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
WO2010045620A1 (en) 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
RU2507253C2 (ru) * 2009-03-27 2014-02-20 Айдгенозише Технише Хохшуле Цюрих Презентируемый в salmonella enterica n-гликан из c. jejuni и его производные
US9163219B2 (en) * 2009-04-14 2015-10-20 Arizona Board Of Regents On Behalf Of Arizona State University Single expression vector for generation of a virus with a segmented genome
WO2010135563A1 (en) 2009-05-22 2010-11-25 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium and methods of antigen and nucleic acid delivery
US9045742B2 (en) * 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9062297B2 (en) 2010-01-13 2015-06-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Yersinia pestis vaccine
WO2011091291A1 (en) 2010-01-22 2011-07-28 The Arizona Board Of Regents For And On Behalf Of Arizona State University BACTERIUM COMPRISING A REGULATED rfaH NUCLEIC ACID
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US9598697B2 (en) 2010-05-28 2017-03-21 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium to decrease tumor growth
CN101920011A (zh) * 2010-06-29 2010-12-22 西北农林科技大学 表达ibdv免疫原基因的重组减毒鼠伤寒沙门氏菌载体疫苗及其制备方法
US9303264B2 (en) 2012-05-18 2016-04-05 The Arizona Board Of Regents For And On Behalf Of Arizona State University Photosynthetic microorganisms expressing thermostable lipase
AU2013311670B2 (en) * 2012-09-06 2018-04-05 Eveliqure Biotechnologies Gmbh A novel live attenuated Shigella vaccine
MY178705A (en) * 2012-09-24 2020-10-20 Hebei Kexing Pharma Co Ltd Method of preparing broad spectrum vaccine for preventing avian colibacillosis
CN103055310B (zh) * 2013-02-04 2014-01-08 齐鲁动物保健品有限公司 一种禽流感（h9 亚型）、大肠埃希氏菌病二联灭活疫苗及其制备方法
US9593339B1 (en) 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
US9580718B2 (en) 2013-06-17 2017-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated live bacteria with increased acid resistance and methods of use thereof
US9868769B2 (en) 2014-01-06 2018-01-16 The United States Of America, As Represented By The Secretary Of Agriculture Mutated Salmonella enteriaca
KR101660294B1 (ko) * 2014-01-08 2016-09-27 전남대학교 산학협력단 glmS 기반의 숙주 벡터 시스템
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
CN105132350B (zh) * 2015-09-30 2018-03-16 四川农业大学 一种减毒鼠伤寒沙门氏菌的构建方法及其所得菌株和应用
CN105483049A (zh) * 2015-12-31 2016-04-13 扬州大学 鸡白痢沙门菌spiC-rfaH双基因敲除减毒株及其DIVA疫苗应用
CN105483051A (zh) * 2015-12-31 2016-04-13 扬州大学 鸡白痢沙门菌spiC-rfaL双基因敲除减毒株及其DIVA疫苗应用
CN105483052A (zh) * 2015-12-31 2016-04-13 扬州大学 鸡白痢沙门菌spiC-rfc双基因敲除减毒株及其DIVA疫苗应用
CN105483048A (zh) * 2015-12-31 2016-04-13 扬州大学 鸡白痢沙门菌spiC-rfaI双基因敲除减毒株及其DIVA疫苗应用
CN105524862A (zh) * 2015-12-31 2016-04-27 扬州大学 鸡白痢沙门菌spiC-rfaJ双基因敲除减毒株及其DIVA疫苗应用
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN106520654B (zh) * 2016-12-12 2019-11-26 扬州大学 一种基于fur基因的猪霍乱沙门氏菌减毒载体菌及其构建方法
CN110520153B (zh) * 2017-01-27 2024-04-02 佛罗里达大学研究基金公司 在禽类中控制肠道沙门氏菌和减少弯曲杆菌的食品安全疫苗
CN117305155A (zh) * 2023-08-28 2023-12-29 江苏省家禽科学研究所 一种抑制沙门氏菌毒力因子的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110588A (en) 1986-08-19 1992-05-05 Enterovax Limited Composite salmonella E. coli, Vibrio cholerae vaccine strains
DE3871489D1 (de) 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
SG46987A1 (en) 1992-04-10 1998-03-20 Schweiz Serum & Impfinst Recombinant live vaccines
GR950300072T1 (en) 1995-10-13 1996-01-31 Schweiz Serum & Impfinst Recombinant live vaccines against Gram-negative enteric pathogens

Also Published As

Publication number Publication date
AU4991499A (en) 2000-02-14
WO2000004919A2 (en) 2000-02-03
CA2338555A1 (en) 2000-02-03
ZA200100976B (en) 2001-08-13
WO2000004919A3 (en) 2000-04-27
US6399074B1 (en) 2002-06-04
EP1100536A2 (en) 2001-05-23
JP2002521345A (ja) 2002-07-16
MXPA01000884A (es) 2002-06-04
CN1315871A (zh) 2001-10-03

Similar Documents

Publication Publication Date Title
BR9912410A (pt) Vacina para imunização de aves, e, processos para imunizar uma ave e para preparar uma vacina para imunizar uma ave
MX9604907A (es) Vacuna de combinacion de virus para la enfermedad de newcastle.
ES2191052T3 (es) Vacuna polinucleotida contra el virus del papiloma.
BR0007936A (pt) Composto, formulação adjuvante imunológica, formulação de vacina, e, processo para estimular uma resposta imune a um antìgeno
BR9712971A (pt) Método para produção de uma vacina para proteção de um hospedeiro contra doença causada com uma cadeia de chlamydia e composição imunológica
CY1105389T1 (el) Hpv-e7 ως αγωγη εναντι του ιου θηλωματων ανθρωπου
BR9912653A (pt) Vìrus de herpes atenuado, cepa de vìrus, célula dendrìtica, processo para produzir um célula, composição farmacêutica, uso de um vìrus, e, processo para executar a terapia de gene em um paciente humano ou animal ou para tratar ou prevenir uma infecção patogênica ou câncer para tratar paciente animal
NO20004972L (no) Derivater av pneumokokkale kolinbindende proteiner for vaksiner
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
AR044234A2 (es) Uso de una composicion que comprende oocistos de eimeria vivos
ES2195169T3 (es) Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion.
ES2538486T3 (es) Preparación de péptidos antigénicos contra el cáncer
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
EA199800746A1 (ru) Способ генерации противовирусного иммунного ответа у человека или животного
BR0212556A (pt) interleucina-12 como um adjuvante de vacina veterinária
BR0310046A (pt) Atenuação de metapneumovìrus
AR054259A1 (es) Vacuna contra virus de papiloma humano (hpv)
ES2177535T3 (es) Vacunas contra protozoos intestinales.
ES2042718T3 (es) Procedimiento para la preparacion de una vacuna para proteger aves de corral contra septicemia producida por e. coli.
HUP0202770A2 (hu) Humán papillómavírus oltóanyag
BR9808226A (pt) Coronavìrus respiratório bovino como uma vacina
DE69633919D1 (de) Mehrzweckvakzine gegen umhüllte viren
BRPI0414073A (pt) método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo
HUP9801917A2 (hu) Immunogén készítmény, eljárás annak előállítására és vakcinaként történő alkalmazására
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8O, 9O E 10O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 1999 DE 28/04/2009.